Smith & Nephew (SNN) Non Operating Interest Expenses (2011 - 2013)

Smith & Nephew (SNN) posted quarterly Non Operating Interest Expenses of $91.0 million for Q4 2013, up 22.97% year-on-year from $74.0 million in Q4 2012, and up 22.97% on a QoQ basis from $74.0 million in Q4 2012.

Smith & Nephew (SNN) Non Operating Interest Expenses (2011 - 2013) Analysis & Trends

Smith & Nephew (SNN) has reported Non Operating Interest Expenses for 3 consecutive years, with $91.0 million the latest figure, recorded in Q4 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2013 91.00 Mn
Dec 31, 2012 74.00 Mn
Dec 31, 2011 90.00 Mn